image: Issue cover
Credit: APSB
https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/vol/15/issue/3
Acta Pharmaceutica Sinica B (APSB) was founded with the goal of creating a global high-level forum centred around drug discovery and pharmaceutical research/application. APSB was included by Chemical Abstracts in 2011, accepted by PubMed Central in 2015, indexed by Science Citation Index in 2017 and has evolved to become one of the most important international journals in the field of pharmaceutical sciences.
APSB is a monthly journal, in English, which publishes significant original research articles, rapid communications and high-quality reviews of recent advances in all areas of pharmaceutical sciences — including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.
Articles of interest in this issue include:
A retrospective cohort study of the efficacy and safety of oral azvudine versus nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 years by Bo Yu, Haiyu Wang, Guangming Li and colleagues, (https://doi.org/10.1016/j.apsb.2024.12.032). This study used five analytical methods to show that azvudine has a therapeutic effect in elderly COVID-19 patients aged over 60 years.
Establishment of interpretable cytotoxicity prediction models using machine learning analysis of transcriptome features by You Wu, Ke Tang, Chunzheng Wang, Hao Song, Fanfan Zhou and Ying Guo, (https://doi.org/10.1016/j.apsb.2025.02.009). This study provides highly accurate models for 50% and 80% cell viability prediction and the key features which could facilitate the MOA study of substance with a narrow therapeutic index.
Parabacteroides distasonis promotes liver regeneration by increasing β-hydroxybutyric acid (BHB) production and BHB-driven STAT3 signals by Manlan Guo, Xiaowen Jiang, Hui Ouyang and colleagues, (https://doi.org/10.1016/j.apsb.2025.01.024). Parabacteroides distasonis promotes liver regeneration by increasing BHB production and BHB-driven STAT3 signals, which provides a relevant argument for using P. distasonis or BHB as a potential strategy for promoting hepatic regeneration after PHx or transplantation.
Other articles include:
Special Column: Nanomedicines for Tumor Microenvironment Modulation
Research articles
Ying He, Ke Zheng, Xifeng Qin, Siyu Wang, ... Zhiqing Pang
Lauren C. Naatz, Shuyun Dong, Brian Evavold, Xiangyang Ye, Mingnan Chen
Yingli Luo, Maoyuan Linghu, Xianyu Luo, Dongdong Li, ... Yinchu Ma
Qiuxia Peng, Xiaolong Li, Chao Fang, Chunyan Zhu, ... Kun Zhang
Review articles
The ubiquitin–proteasome system: A potential target for the MASLD
Yue Liu, Meijia Qian, Yonghao Li, Xin Dong, ... Qiaojun He
Patil Ashwini, Bodhankar Subhash, Muthal Amol, Dileep Kumar, ... Kulkarni Ravindra
Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizon
Martin Kufa, Vladimir Finger, Ondrej Kovar, Ondrej Soukup, ... Jan Korabecny
Research articles
Targeting farnesoid X receptor as aging intervention therapy
Lijun Zhang, Jing Yu, Xiaoyan Gao, Yingxuan Yan, ... Shengjie Fan
Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis
Kaifeng Wang, Zhixian Lan, Heqi Zhou, Rong Fan, ... Jian Sun
Jiahui Chen, Liping Zhang, Ting Xie, Xiao Zhang, ... Deli Dong
Xiong Zhang, Yatian Yang, Hongye Zou, Yang Yang, ... Hong-Wu Chen
ShaoXi Ke, Ping Dong, Yi Mei, JiaQi Wang, ... QiongYao Tang
Joo-Hui Han, Jong-Beom Heo, Hyung-Won Lee, Min-Ho Park, ... Chang-Seon Myung
Yuanfang Guo, Jie Wang, Dongmei Zhang, Yufeng Tang, ... Junlian Gu
Chuanjing Cheng, Kaixin Liu, Jinling Zhang, Yanqi Han, ... Gang Bai
Weile Ye, Pinglian Yang, Mei Jin, Jiami Zou, ... Zhiping Liu
STK39 inhibits antiviral immune response by inhibiting DCAF1-mediated PP2A degradation
Chengfei Zhang, Ping Xu, Yongsheng Wang, Xin Chen, ... Hongping Xia
BRD4 regulates m6A of ESPL1 mRNA via interaction with ALKBH5 to modulate breast cancer progression
Haisheng Zhang, Linlin Lu, Cheng Yi, Tao Jiang, ... Hongsheng Wang
Qianying Ouyang, Jiajia Cui, Yang Wang, Ke Liu, ... Jiye Yin
Dandan Xiao, Wenguang Chang, Xiang Ao, Lin Ye, ... Jianxun Wang
Yuncheng Bei, Sijie Wang, Rui Wang, Owais Ahmad, ... Pingping Shen
Wenxiang Hong, Hongbo Ma, Zhaoxu Yang, Jiaying Wang, ... Qinjie Weng
Yanghao Chen, Bozhi Ye, Diyun Xu, Wante Lin, ... Guang Liang
Yuheng Jin, Xuxin Qi, Xiaoli Yu, Xirui Cheng, ... Xiaowu Dong
Taotao Lu, Hongguang Han, Chaohui Wu, Qian Li, ... Baoli Li
Letter to the editor
Lycorine hydrochloride directly targets UBA1 to suppress cellular senescence
Jiaqing Yang, Junhao Xu, Ziheng Qiu, Zhiyong Mao, ... Guizhu Wu
Highlights
Monocytes in the brain–heart crosstalk control sleep under myocardial infarction
Meng Mao, Hailong Bing, Jianping Ye, Zhengyuan Xia, Qinjun Chu
Engineered bacteria assist CAR-cell immunotherapy
Tianyu Shao, Manman Xu, Jie Li, Xiao Zhao
Silencing excessive stress response of neurons — a new approach to treat neurodegeneration diseases
Chunyang Li, Hongkai Lian, Xiwen Ma, Jianping Ye
Commentaries
Liquid–liquid phase separation-assembled coacervate vesicles for biopharmaceutical delivery
Zao Ji, Jianbin Bi, Hong-Xu Liu, Heran Li
Ranran Sun, Yihang Song, Zhe Li, Daming Wang, Zujiang Yu
Wenchao Wei, Bernd Schnabl
# # # # # #
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association.
For more information please visit https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/
Editorial Board: https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/editorial-board
APSB is available on ScienceDirect (https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b).
Submissions to APSB may be made using Editorial Manager® (https://www.editorialmanager.com/apsb/default.aspx).
CiteScore: 22.4
Impact Factor: 14.8
JIF without self-citation: 13.9
ISSN 2211-3835
# # # # #
Journal
Acta Pharmaceutica Sinica B